Global IBS-C Drug Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028
The IBS-C Drug market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our (Global Info Research) latest study, due to COVID-19 pandemic, the global IBS-C Drug market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of USD million by 2028 with a CAGR of % during review period. Hospital Pharmacies accounting for % of the IBS-C Drug global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While Amitiza segment is altered to a % CAGR between 2022 and 2028.
Global key manufacturers of IBS-C Drug include Allergan, Takeda, Sucampo Pharmaceuticals, IM HealthScience, and , etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
IBS-C Drug market is split by Type and by Distribution Channel. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for sales by Type and by Distribution Channel in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Chapter 1, to describe IBS-C Drug product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of IBS-C Drug, with price, sales, revenue and global market share of IBS-C Drug from 2019 to 2022.
Chapter 3, the IBS-C Drug competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the IBS-C Drug breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, distribution channel, from 2017 to 2028.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2017 to 2022.and IBS-C Drug market forecast, by regions, type and distribution channel, with sales and revenue, from 2023 to 2028.
Chapter 12, the key raw materials and key suppliers, and industry chain of IBS-C Drug.
Chapter 13, 14, and 15, to describe IBS-C Drug sales channel, distributors, customers, research findings and conclusion, appendix and data source.
According to our (Global Info Research) latest study, due to COVID-19 pandemic, the global IBS-C Drug market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of USD million by 2028 with a CAGR of % during review period. Hospital Pharmacies accounting for % of the IBS-C Drug global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While Amitiza segment is altered to a % CAGR between 2022 and 2028.
Global key manufacturers of IBS-C Drug include Allergan, Takeda, Sucampo Pharmaceuticals, IM HealthScience, and , etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
IBS-C Drug market is split by Type and by Distribution Channel. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for sales by Type and by Distribution Channel in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
- Amitiza
- Lactulose
- Milk of Magnesia
- LINZESS (Linaclotide)
- Others
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
- Allergan
- Takeda
- Sucampo Pharmaceuticals
- IM HealthScience
- North America (United States, Canada and Mexico)
- Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
- Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
- South America (Brazil, Argentina, Colombia, and Rest of South America)
- Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
Chapter 1, to describe IBS-C Drug product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of IBS-C Drug, with price, sales, revenue and global market share of IBS-C Drug from 2019 to 2022.
Chapter 3, the IBS-C Drug competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the IBS-C Drug breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, distribution channel, from 2017 to 2028.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2017 to 2022.and IBS-C Drug market forecast, by regions, type and distribution channel, with sales and revenue, from 2023 to 2028.
Chapter 12, the key raw materials and key suppliers, and industry chain of IBS-C Drug.
Chapter 13, 14, and 15, to describe IBS-C Drug sales channel, distributors, customers, research findings and conclusion, appendix and data source.
1 MARKET OVERVIEW
1.1 IBS-C Drug Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global IBS-C Drug Revenue by Type: 2017 Versus 2021 Versus 2028
1.2.2 Amitiza
1.2.3 Lactulose
1.2.4 Milk of Magnesia
1.2.5 LINZESS (Linaclotide)
1.2.6 Others
1.3 Market Analysis by Distribution Channel
1.3.1 Overview: Global IBS-C Drug Revenue by Distribution Channel: 2017 Versus 2021 Versus 2028
1.3.2 Hospital Pharmacies
1.3.3 Retail Pharmacies
1.3.4 Online Pharmacies
1.4 Global IBS-C Drug Market Size & Forecast
1.4.1 Global IBS-C Drug Sales in Value (2017 & 2021 & 2028)
1.4.2 Global IBS-C Drug Sales in Volume (2017-2028)
1.4.3 Global IBS-C Drug Price (2017-2028)
1.5 Global IBS-C Drug Production Capacity Analysis
1.5.1 Global IBS-C Drug Total Production Capacity (2017-2028)
1.5.2 Global IBS-C Drug Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 IBS-C Drug Market Drivers
1.6.2 IBS-C Drug Market Restraints
1.6.3 IBS-C Drug Trends Analysis
2 MANUFACTURERS PROFILES
2.1 Allergan
2.1.1 Allergan Details
2.1.2 Allergan Major Business
2.1.3 Allergan IBS-C Drug Product and Services
2.1.4 Allergan IBS-C Drug Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2 Takeda
2.2.1 Takeda Details
2.2.2 Takeda Major Business
2.2.3 Takeda IBS-C Drug Product and Services
2.2.4 Takeda IBS-C Drug Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.3 Sucampo Pharmaceuticals
2.3.1 Sucampo Pharmaceuticals Details
2.3.2 Sucampo Pharmaceuticals Major Business
2.3.3 Sucampo Pharmaceuticals IBS-C Drug Product and Services
2.3.4 Sucampo Pharmaceuticals IBS-C Drug Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.4 IM HealthScience
2.4.1 IM HealthScience Details
2.4.2 IM HealthScience Major Business
2.4.3 IM HealthScience IBS-C Drug Product and Services
2.4.4 IM HealthScience IBS-C Drug Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
3 IBS-C DRUG BREAKDOWN DATA BY MANUFACTURER
3.1 Global IBS-C Drug Sales in Volume by Manufacturer (2019, 2020, 2021, and 2022)
3.2 Global IBS-C Drug Revenue by Manufacturer (2019, 2020, 2021, and 2022)
3.3 Key Manufacturer Market Position in IBS-C Drug
3.4 Market Concentration Rate
3.4.1 Top 3 IBS-C Drug Manufacturer Market Share in 2021
3.4.2 Top 6 IBS-C Drug Manufacturer Market Share in 2021
3.5 Global IBS-C Drug Production Capacity by Company: 2021 VS 2022
3.6 Manufacturer by Geography: Head Office and IBS-C Drug Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 MARKET ANALYSIS BY REGION
4.1 Global IBS-C Drug Market Size by Region
4.1.1 Global IBS-C Drug Sales in Volume by Region (2017-2028)
4.1.2 Global IBS-C Drug Revenue by Region (2017-2028)
4.2 North America IBS-C Drug Revenue (2017-2028)
4.3 Europe IBS-C Drug Revenue (2017-2028)
4.4 Asia-Pacific IBS-C Drug Revenue (2017-2028)
4.5 South America IBS-C Drug Revenue (2017-2028)
4.6 Middle East and Africa IBS-C Drug Revenue (2017-2028)
5 MARKET SEGMENT BY TYPE
5.1 Global IBS-C Drug Sales in Volume by Type (2017-2028)
5.2 Global IBS-C Drug Revenue by Type (2017-2028)
5.3 Global IBS-C Drug Price by Type (2017-2028)
6 MARKET SEGMENT BY DISTRIBUTION CHANNEL
6.1 Global IBS-C Drug Sales in Volume by Distribution Channel (2017-2028)
6.2 Global IBS-C Drug Revenue by Distribution Channel (2017-2028)
6.3 Global IBS-C Drug Price by Distribution Channel (2017-2028)
7 NORTH AMERICA BY COUNTRY, BY TYPE, AND BY DISTRIBUTION CHANNEL
7.1 North America IBS-C Drug Sales by Type (2017-2028)
7.2 North America IBS-C Drug Sales by Distribution Channel (2017-2028)
7.3 North America IBS-C Drug Market Size by Country
7.3.1 North America IBS-C Drug Sales in Volume by Country (2017-2028)
7.3.2 North America IBS-C Drug Revenue by Country (2017-2028)
7.3.3 United States Market Size and Forecast (2017-2028)
7.3.4 Canada Market Size and Forecast (2017-2028)
7.3.5 Mexico Market Size and Forecast (2017-2028)
8 EUROPE BY COUNTRY, BY TYPE, AND BY DISTRIBUTION CHANNEL
8.1 Europe IBS-C Drug Sales by Type (2017-2028)
8.2 Europe IBS-C Drug Sales by Distribution Channel (2017-2028)
8.3 Europe IBS-C Drug Market Size by Country
8.3.1 Europe IBS-C Drug Sales in Volume by Country (2017-2028)
8.3.2 Europe IBS-C Drug Revenue by Country (2017-2028)
8.3.3 Germany Market Size and Forecast (2017-2028)
8.3.4 France Market Size and Forecast (2017-2028)
8.3.5 United Kingdom Market Size and Forecast (2017-2028)
8.3.6 Russia Market Size and Forecast (2017-2028)
8.3.7 Italy Market Size and Forecast (2017-2028)
9 ASIA-PACIFIC BY REGION, BY TYPE, AND BY DISTRIBUTION CHANNEL
9.1 Asia-Pacific IBS-C Drug Sales by Type (2017-2028)
9.2 Asia-Pacific IBS-C Drug Sales by Distribution Channel (2017-2028)
9.3 Asia-Pacific IBS-C Drug Market Size by Region
9.3.1 Asia-Pacific IBS-C Drug Sales in Volume by Region (2017-2028)
9.3.2 Asia-Pacific IBS-C Drug Revenue by Region (2017-2028)
9.3.3 China Market Size and Forecast (2017-2028)
9.3.4 Japan Market Size and Forecast (2017-2028)
9.3.5 Korea Market Size and Forecast (2017-2028)
9.3.6 India Market Size and Forecast (2017-2028)
9.3.7 Southeast Asia Market Size and Forecast (2017-2028)
9.3.8 Australia Market Size and Forecast (2017-2028)
10 SOUTH AMERICA BY REGION, BY TYPE, AND BY DISTRIBUTION CHANNEL
10.1 South America IBS-C Drug Sales by Type (2017-2028)
10.2 South America IBS-C Drug Sales by Distribution Channel (2017-2028)
10.3 South America IBS-C Drug Market Size by Country
10.3.1 South America IBS-C Drug Sales in Volume by Country (2017-2028)
10.3.2 South America IBS-C Drug Revenue by Country (2017-2028)
10.3.3 Brazil Market Size and Forecast (2017-2028)
10.3.4 Argentina Market Size and Forecast (2017-2028)
11 MIDDLE EAST & AFRICA BY COUNTRY, BY TYPE, AND BY DISTRIBUTION CHANNEL
11.1 Middle East & Africa IBS-C Drug Sales by Type (2017-2028)
11.2 Middle East & Africa IBS-C Drug Sales by Distribution Channel (2017-2028)
11.3 Middle East & Africa IBS-C Drug Market Size by Country
11.3.1 Middle East & Africa IBS-C Drug Sales in Volume by Country (2017-2028)
11.3.2 Middle East & Africa IBS-C Drug Revenue by Country (2017-2028)
11.3.3 Turkey Market Size and Forecast (2017-2028)
11.3.4 Egypt Market Size and Forecast (2017-2028)
11.3.5 Saudi Arabia Market Size and Forecast (2017-2028)
11.3.6 South Africa Market Size and Forecast (2017-2028)
12 RAW MATERIAL AND INDUSTRY CHAIN
12.1 Raw Material of IBS-C Drug and Key Manufacturers
12.2 Manufacturing Costs Percentage of IBS-C Drug
12.3 IBS-C Drug Production Process
12.4 IBS-C Drug Industrial Chain
13 SALES CHANNEL, DISTRIBUTORS, TRADERS AND DEALERS
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 IBS-C Drug Typical Distributors
13.3 IBS-C Drug Typical Customers
14 RESEARCH FINDINGS AND CONCLUSION
15 APPENDIX
15.1 Methodology
15.2 Research Process and Data Source
15.3 Disclaimer
1.1 IBS-C Drug Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global IBS-C Drug Revenue by Type: 2017 Versus 2021 Versus 2028
1.2.2 Amitiza
1.2.3 Lactulose
1.2.4 Milk of Magnesia
1.2.5 LINZESS (Linaclotide)
1.2.6 Others
1.3 Market Analysis by Distribution Channel
1.3.1 Overview: Global IBS-C Drug Revenue by Distribution Channel: 2017 Versus 2021 Versus 2028
1.3.2 Hospital Pharmacies
1.3.3 Retail Pharmacies
1.3.4 Online Pharmacies
1.4 Global IBS-C Drug Market Size & Forecast
1.4.1 Global IBS-C Drug Sales in Value (2017 & 2021 & 2028)
1.4.2 Global IBS-C Drug Sales in Volume (2017-2028)
1.4.3 Global IBS-C Drug Price (2017-2028)
1.5 Global IBS-C Drug Production Capacity Analysis
1.5.1 Global IBS-C Drug Total Production Capacity (2017-2028)
1.5.2 Global IBS-C Drug Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 IBS-C Drug Market Drivers
1.6.2 IBS-C Drug Market Restraints
1.6.3 IBS-C Drug Trends Analysis
2 MANUFACTURERS PROFILES
2.1 Allergan
2.1.1 Allergan Details
2.1.2 Allergan Major Business
2.1.3 Allergan IBS-C Drug Product and Services
2.1.4 Allergan IBS-C Drug Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2 Takeda
2.2.1 Takeda Details
2.2.2 Takeda Major Business
2.2.3 Takeda IBS-C Drug Product and Services
2.2.4 Takeda IBS-C Drug Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.3 Sucampo Pharmaceuticals
2.3.1 Sucampo Pharmaceuticals Details
2.3.2 Sucampo Pharmaceuticals Major Business
2.3.3 Sucampo Pharmaceuticals IBS-C Drug Product and Services
2.3.4 Sucampo Pharmaceuticals IBS-C Drug Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.4 IM HealthScience
2.4.1 IM HealthScience Details
2.4.2 IM HealthScience Major Business
2.4.3 IM HealthScience IBS-C Drug Product and Services
2.4.4 IM HealthScience IBS-C Drug Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
3 IBS-C DRUG BREAKDOWN DATA BY MANUFACTURER
3.1 Global IBS-C Drug Sales in Volume by Manufacturer (2019, 2020, 2021, and 2022)
3.2 Global IBS-C Drug Revenue by Manufacturer (2019, 2020, 2021, and 2022)
3.3 Key Manufacturer Market Position in IBS-C Drug
3.4 Market Concentration Rate
3.4.1 Top 3 IBS-C Drug Manufacturer Market Share in 2021
3.4.2 Top 6 IBS-C Drug Manufacturer Market Share in 2021
3.5 Global IBS-C Drug Production Capacity by Company: 2021 VS 2022
3.6 Manufacturer by Geography: Head Office and IBS-C Drug Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 MARKET ANALYSIS BY REGION
4.1 Global IBS-C Drug Market Size by Region
4.1.1 Global IBS-C Drug Sales in Volume by Region (2017-2028)
4.1.2 Global IBS-C Drug Revenue by Region (2017-2028)
4.2 North America IBS-C Drug Revenue (2017-2028)
4.3 Europe IBS-C Drug Revenue (2017-2028)
4.4 Asia-Pacific IBS-C Drug Revenue (2017-2028)
4.5 South America IBS-C Drug Revenue (2017-2028)
4.6 Middle East and Africa IBS-C Drug Revenue (2017-2028)
5 MARKET SEGMENT BY TYPE
5.1 Global IBS-C Drug Sales in Volume by Type (2017-2028)
5.2 Global IBS-C Drug Revenue by Type (2017-2028)
5.3 Global IBS-C Drug Price by Type (2017-2028)
6 MARKET SEGMENT BY DISTRIBUTION CHANNEL
6.1 Global IBS-C Drug Sales in Volume by Distribution Channel (2017-2028)
6.2 Global IBS-C Drug Revenue by Distribution Channel (2017-2028)
6.3 Global IBS-C Drug Price by Distribution Channel (2017-2028)
7 NORTH AMERICA BY COUNTRY, BY TYPE, AND BY DISTRIBUTION CHANNEL
7.1 North America IBS-C Drug Sales by Type (2017-2028)
7.2 North America IBS-C Drug Sales by Distribution Channel (2017-2028)
7.3 North America IBS-C Drug Market Size by Country
7.3.1 North America IBS-C Drug Sales in Volume by Country (2017-2028)
7.3.2 North America IBS-C Drug Revenue by Country (2017-2028)
7.3.3 United States Market Size and Forecast (2017-2028)
7.3.4 Canada Market Size and Forecast (2017-2028)
7.3.5 Mexico Market Size and Forecast (2017-2028)
8 EUROPE BY COUNTRY, BY TYPE, AND BY DISTRIBUTION CHANNEL
8.1 Europe IBS-C Drug Sales by Type (2017-2028)
8.2 Europe IBS-C Drug Sales by Distribution Channel (2017-2028)
8.3 Europe IBS-C Drug Market Size by Country
8.3.1 Europe IBS-C Drug Sales in Volume by Country (2017-2028)
8.3.2 Europe IBS-C Drug Revenue by Country (2017-2028)
8.3.3 Germany Market Size and Forecast (2017-2028)
8.3.4 France Market Size and Forecast (2017-2028)
8.3.5 United Kingdom Market Size and Forecast (2017-2028)
8.3.6 Russia Market Size and Forecast (2017-2028)
8.3.7 Italy Market Size and Forecast (2017-2028)
9 ASIA-PACIFIC BY REGION, BY TYPE, AND BY DISTRIBUTION CHANNEL
9.1 Asia-Pacific IBS-C Drug Sales by Type (2017-2028)
9.2 Asia-Pacific IBS-C Drug Sales by Distribution Channel (2017-2028)
9.3 Asia-Pacific IBS-C Drug Market Size by Region
9.3.1 Asia-Pacific IBS-C Drug Sales in Volume by Region (2017-2028)
9.3.2 Asia-Pacific IBS-C Drug Revenue by Region (2017-2028)
9.3.3 China Market Size and Forecast (2017-2028)
9.3.4 Japan Market Size and Forecast (2017-2028)
9.3.5 Korea Market Size and Forecast (2017-2028)
9.3.6 India Market Size and Forecast (2017-2028)
9.3.7 Southeast Asia Market Size and Forecast (2017-2028)
9.3.8 Australia Market Size and Forecast (2017-2028)
10 SOUTH AMERICA BY REGION, BY TYPE, AND BY DISTRIBUTION CHANNEL
10.1 South America IBS-C Drug Sales by Type (2017-2028)
10.2 South America IBS-C Drug Sales by Distribution Channel (2017-2028)
10.3 South America IBS-C Drug Market Size by Country
10.3.1 South America IBS-C Drug Sales in Volume by Country (2017-2028)
10.3.2 South America IBS-C Drug Revenue by Country (2017-2028)
10.3.3 Brazil Market Size and Forecast (2017-2028)
10.3.4 Argentina Market Size and Forecast (2017-2028)
11 MIDDLE EAST & AFRICA BY COUNTRY, BY TYPE, AND BY DISTRIBUTION CHANNEL
11.1 Middle East & Africa IBS-C Drug Sales by Type (2017-2028)
11.2 Middle East & Africa IBS-C Drug Sales by Distribution Channel (2017-2028)
11.3 Middle East & Africa IBS-C Drug Market Size by Country
11.3.1 Middle East & Africa IBS-C Drug Sales in Volume by Country (2017-2028)
11.3.2 Middle East & Africa IBS-C Drug Revenue by Country (2017-2028)
11.3.3 Turkey Market Size and Forecast (2017-2028)
11.3.4 Egypt Market Size and Forecast (2017-2028)
11.3.5 Saudi Arabia Market Size and Forecast (2017-2028)
11.3.6 South Africa Market Size and Forecast (2017-2028)
12 RAW MATERIAL AND INDUSTRY CHAIN
12.1 Raw Material of IBS-C Drug and Key Manufacturers
12.2 Manufacturing Costs Percentage of IBS-C Drug
12.3 IBS-C Drug Production Process
12.4 IBS-C Drug Industrial Chain
13 SALES CHANNEL, DISTRIBUTORS, TRADERS AND DEALERS
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 IBS-C Drug Typical Distributors
13.3 IBS-C Drug Typical Customers
14 RESEARCH FINDINGS AND CONCLUSION
15 APPENDIX
15.1 Methodology
15.2 Research Process and Data Source
15.3 Disclaimer
LIST OF TABLES
Table 1. Global IBS-C Drug Revenue by Type, (USD Million), 2017 & 2021 & 2028
Table 2. Global IBS-C Drug Revenue by Distribution Channel, (USD Million), 2017 & 2021 & 2028
Table 3. Allergan Basic Information, Manufacturing Base and Competitors
Table 4. Allergan Major Business
Table 5. Allergan IBS-C Drug Product and Services
Table 6. Allergan IBS-C Drug Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 7. Takeda Basic Information, Manufacturing Base and Competitors
Table 8. Takeda Major Business
Table 9. Takeda IBS-C Drug Product and Services
Table 10. Takeda IBS-C Drug Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 11. Sucampo Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 12. Sucampo Pharmaceuticals Major Business
Table 13. Sucampo Pharmaceuticals IBS-C Drug Product and Services
Table 14. Sucampo Pharmaceuticals IBS-C Drug Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 15. IM HealthScience Basic Information, Manufacturing Base and Competitors
Table 16. IM HealthScience Major Business
Table 17. IM HealthScience IBS-C Drug Product and Services
Table 18. IM HealthScience IBS-C Drug Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 19. Global IBS-C Drug Sales by Manufacturer (2019, 2020, 2021, and 2022) & (K Units)
Table 20. Global IBS-C Drug Revenue by Manufacturer (2019, 2020, 2021, and 2022) & (USD Million)
Table 21. Market Position of Manufacturers in IBS-C Drug, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2021
Table 22. Global IBS-C Drug Production Capacity by Company, (K Units): 2020 VS 2021
Table 23. Head Office and IBS-C Drug Production Site of Key Manufacturer
Table 24. IBS-C Drug New Entrant and Capacity Expansion Plans
Table 25. IBS-C Drug Mergers & Acquisitions in the Past Five Years
Table 26. Global IBS-C Drug Sales by Region (2017-2022) & (K Units)
Table 27. Global IBS-C Drug Sales by Region (2023-2028) & (K Units)
Table 28. Global IBS-C Drug Revenue by Region (2017-2022) & (USD Million)
Table 29. Global IBS-C Drug Revenue by Region (2023-2028) & (USD Million)
Table 30. Global IBS-C Drug Sales by Type (2017-2022) & (K Units)
Table 31. Global IBS-C Drug Sales by Type (2023-2028) & (K Units)
Table 32. Global IBS-C Drug Revenue by Type (2017-2022) & (USD Million)
Table 33. Global IBS-C Drug Revenue by Type (2023-2028) & (USD Million)
Table 34. Global IBS-C Drug Price by Type (2017-2022) & (USD/Unit)
Table 35. Global IBS-C Drug Price by Type (2023-2028) & (USD/Unit)
Table 36. Global IBS-C Drug Sales by Distribution Channel (2017-2022) & (K Units)
Table 37. Global IBS-C Drug Sales by Distribution Channel (2023-2028) & (K Units)
Table 38. Global IBS-C Drug Revenue by Distribution Channel (2017-2022) & (USD Million)
Table 39. Global IBS-C Drug Revenue by Distribution Channel (2023-2028) & (USD Million)
Table 40. Global IBS-C Drug Price by Distribution Channel (2017-2022) & (USD/Unit)
Table 41. Global IBS-C Drug Price by Distribution Channel (2023-2028) & (USD/Unit)
Table 42. North America IBS-C Drug Sales by Country (2017-2022) & (K Units)
Table 43. North America IBS-C Drug Sales by Country (2023-2028) & (K Units)
Table 44. North America IBS-C Drug Revenue by Country (2017-2022) & (USD Million)
Table 45. North America IBS-C Drug Revenue by Country (2023-2028) & (USD Million)
Table 46. North America IBS-C Drug Sales by Type (2017-2022) & (K Units)
Table 47. North America IBS-C Drug Sales by Type (2023-2028) & (K Units)
Table 48. North America IBS-C Drug Sales by Distribution Channel (2017-2022) & (K Units)
Table 49. North America IBS-C Drug Sales by Distribution Channel (2023-2028) & (K Units)
Table 50. Europe IBS-C Drug Sales by Country (2017-2022) & (K Units)
Table 51. Europe IBS-C Drug Sales by Country (2023-2028) & (K Units)
Table 52. Europe IBS-C Drug Revenue by Country (2017-2022) & (USD Million)
Table 53. Europe IBS-C Drug Revenue by Country (2023-2028) & (USD Million)
Table 54. Europe IBS-C Drug Sales by Type (2017-2022) & (K Units)
Table 55. Europe IBS-C Drug Sales by Type (2023-2028) & (K Units)
Table 56. Europe IBS-C Drug Sales by Distribution Channel (2017-2022) & (K Units)
Table 57. Europe IBS-C Drug Sales by Distribution Channel (2023-2028) & (K Units)
Table 58. Asia-Pacific IBS-C Drug Sales by Region (2017-2022) & (K Units)
Table 59. Asia-Pacific IBS-C Drug Sales by Region (2023-2028) & (K Units)
Table 60. Asia-Pacific IBS-C Drug Revenue by Region (2017-2022) & (USD Million)
Table 61. Asia-Pacific IBS-C Drug Revenue by Region (2023-2028) & (USD Million)
Table 62. Asia-Pacific IBS-C Drug Sales by Type (2017-2022) & (K Units)
Table 63. Asia-Pacific IBS-C Drug Sales by Type (2023-2028) & (K Units)
Table 64. Asia-Pacific IBS-C Drug Sales by Distribution Channel (2017-2022) & (K Units)
Table 65. Asia-Pacific IBS-C Drug Sales by Distribution Channel (2023-2028) & (K Units)
Table 66. South America IBS-C Drug Sales by Country (2017-2022) & (K Units)
Table 67. South America IBS-C Drug Sales by Country (2023-2028) & (K Units)
Table 68. South America IBS-C Drug Revenue by Country (2017-2022) & (USD Million)
Table 69. South America IBS-C Drug Revenue by Country (2023-2028) & (USD Million)
Table 70. South America IBS-C Drug Sales by Type (2017-2022) & (K Units)
Table 71. South America IBS-C Drug Sales by Type (2023-2028) & (K Units)
Table 72. South America IBS-C Drug Sales by Distribution Channel (2017-2022) & (K Units)
Table 73. South America IBS-C Drug Sales by Distribution Channel (2023-2028) & (K Units)
Table 74. Middle East & Africa IBS-C Drug Sales by Region (2017-2022) & (K Units)
Table 75. Middle East & Africa IBS-C Drug Sales by Region (2023-2028) & (K Units)
Table 76. Middle East & Africa IBS-C Drug Revenue by Region (2017-2022) & (USD Million)
Table 77. Middle East & Africa IBS-C Drug Revenue by Region (2023-2028) & (USD Million)
Table 78. Middle East & Africa IBS-C Drug Sales by Type (2017-2022) & (K Units)
Table 79. Middle East & Africa IBS-C Drug Sales by Type (2023-2028) & (K Units)
Table 80. Middle East & Africa IBS-C Drug Sales by Distribution Channel (2017-2022) & (K Units)
Table 81. Middle East & Africa IBS-C Drug Sales by Distribution Channel (2023-2028) & (K Units)
Table 82. IBS-C Drug Raw Material
Table 83. Key Manufacturers of IBS-C Drug Raw Materials
Table 84. Direct Channel Pros & Cons
Table 85. Indirect Channel Pros & Cons
Table 86. IBS-C Drug Typical Distributors
Table 87. IBS-C Drug Typical Customers
Table 1. Global IBS-C Drug Revenue by Type, (USD Million), 2017 & 2021 & 2028
Table 2. Global IBS-C Drug Revenue by Distribution Channel, (USD Million), 2017 & 2021 & 2028
Table 3. Allergan Basic Information, Manufacturing Base and Competitors
Table 4. Allergan Major Business
Table 5. Allergan IBS-C Drug Product and Services
Table 6. Allergan IBS-C Drug Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 7. Takeda Basic Information, Manufacturing Base and Competitors
Table 8. Takeda Major Business
Table 9. Takeda IBS-C Drug Product and Services
Table 10. Takeda IBS-C Drug Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 11. Sucampo Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 12. Sucampo Pharmaceuticals Major Business
Table 13. Sucampo Pharmaceuticals IBS-C Drug Product and Services
Table 14. Sucampo Pharmaceuticals IBS-C Drug Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 15. IM HealthScience Basic Information, Manufacturing Base and Competitors
Table 16. IM HealthScience Major Business
Table 17. IM HealthScience IBS-C Drug Product and Services
Table 18. IM HealthScience IBS-C Drug Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 19. Global IBS-C Drug Sales by Manufacturer (2019, 2020, 2021, and 2022) & (K Units)
Table 20. Global IBS-C Drug Revenue by Manufacturer (2019, 2020, 2021, and 2022) & (USD Million)
Table 21. Market Position of Manufacturers in IBS-C Drug, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2021
Table 22. Global IBS-C Drug Production Capacity by Company, (K Units): 2020 VS 2021
Table 23. Head Office and IBS-C Drug Production Site of Key Manufacturer
Table 24. IBS-C Drug New Entrant and Capacity Expansion Plans
Table 25. IBS-C Drug Mergers & Acquisitions in the Past Five Years
Table 26. Global IBS-C Drug Sales by Region (2017-2022) & (K Units)
Table 27. Global IBS-C Drug Sales by Region (2023-2028) & (K Units)
Table 28. Global IBS-C Drug Revenue by Region (2017-2022) & (USD Million)
Table 29. Global IBS-C Drug Revenue by Region (2023-2028) & (USD Million)
Table 30. Global IBS-C Drug Sales by Type (2017-2022) & (K Units)
Table 31. Global IBS-C Drug Sales by Type (2023-2028) & (K Units)
Table 32. Global IBS-C Drug Revenue by Type (2017-2022) & (USD Million)
Table 33. Global IBS-C Drug Revenue by Type (2023-2028) & (USD Million)
Table 34. Global IBS-C Drug Price by Type (2017-2022) & (USD/Unit)
Table 35. Global IBS-C Drug Price by Type (2023-2028) & (USD/Unit)
Table 36. Global IBS-C Drug Sales by Distribution Channel (2017-2022) & (K Units)
Table 37. Global IBS-C Drug Sales by Distribution Channel (2023-2028) & (K Units)
Table 38. Global IBS-C Drug Revenue by Distribution Channel (2017-2022) & (USD Million)
Table 39. Global IBS-C Drug Revenue by Distribution Channel (2023-2028) & (USD Million)
Table 40. Global IBS-C Drug Price by Distribution Channel (2017-2022) & (USD/Unit)
Table 41. Global IBS-C Drug Price by Distribution Channel (2023-2028) & (USD/Unit)
Table 42. North America IBS-C Drug Sales by Country (2017-2022) & (K Units)
Table 43. North America IBS-C Drug Sales by Country (2023-2028) & (K Units)
Table 44. North America IBS-C Drug Revenue by Country (2017-2022) & (USD Million)
Table 45. North America IBS-C Drug Revenue by Country (2023-2028) & (USD Million)
Table 46. North America IBS-C Drug Sales by Type (2017-2022) & (K Units)
Table 47. North America IBS-C Drug Sales by Type (2023-2028) & (K Units)
Table 48. North America IBS-C Drug Sales by Distribution Channel (2017-2022) & (K Units)
Table 49. North America IBS-C Drug Sales by Distribution Channel (2023-2028) & (K Units)
Table 50. Europe IBS-C Drug Sales by Country (2017-2022) & (K Units)
Table 51. Europe IBS-C Drug Sales by Country (2023-2028) & (K Units)
Table 52. Europe IBS-C Drug Revenue by Country (2017-2022) & (USD Million)
Table 53. Europe IBS-C Drug Revenue by Country (2023-2028) & (USD Million)
Table 54. Europe IBS-C Drug Sales by Type (2017-2022) & (K Units)
Table 55. Europe IBS-C Drug Sales by Type (2023-2028) & (K Units)
Table 56. Europe IBS-C Drug Sales by Distribution Channel (2017-2022) & (K Units)
Table 57. Europe IBS-C Drug Sales by Distribution Channel (2023-2028) & (K Units)
Table 58. Asia-Pacific IBS-C Drug Sales by Region (2017-2022) & (K Units)
Table 59. Asia-Pacific IBS-C Drug Sales by Region (2023-2028) & (K Units)
Table 60. Asia-Pacific IBS-C Drug Revenue by Region (2017-2022) & (USD Million)
Table 61. Asia-Pacific IBS-C Drug Revenue by Region (2023-2028) & (USD Million)
Table 62. Asia-Pacific IBS-C Drug Sales by Type (2017-2022) & (K Units)
Table 63. Asia-Pacific IBS-C Drug Sales by Type (2023-2028) & (K Units)
Table 64. Asia-Pacific IBS-C Drug Sales by Distribution Channel (2017-2022) & (K Units)
Table 65. Asia-Pacific IBS-C Drug Sales by Distribution Channel (2023-2028) & (K Units)
Table 66. South America IBS-C Drug Sales by Country (2017-2022) & (K Units)
Table 67. South America IBS-C Drug Sales by Country (2023-2028) & (K Units)
Table 68. South America IBS-C Drug Revenue by Country (2017-2022) & (USD Million)
Table 69. South America IBS-C Drug Revenue by Country (2023-2028) & (USD Million)
Table 70. South America IBS-C Drug Sales by Type (2017-2022) & (K Units)
Table 71. South America IBS-C Drug Sales by Type (2023-2028) & (K Units)
Table 72. South America IBS-C Drug Sales by Distribution Channel (2017-2022) & (K Units)
Table 73. South America IBS-C Drug Sales by Distribution Channel (2023-2028) & (K Units)
Table 74. Middle East & Africa IBS-C Drug Sales by Region (2017-2022) & (K Units)
Table 75. Middle East & Africa IBS-C Drug Sales by Region (2023-2028) & (K Units)
Table 76. Middle East & Africa IBS-C Drug Revenue by Region (2017-2022) & (USD Million)
Table 77. Middle East & Africa IBS-C Drug Revenue by Region (2023-2028) & (USD Million)
Table 78. Middle East & Africa IBS-C Drug Sales by Type (2017-2022) & (K Units)
Table 79. Middle East & Africa IBS-C Drug Sales by Type (2023-2028) & (K Units)
Table 80. Middle East & Africa IBS-C Drug Sales by Distribution Channel (2017-2022) & (K Units)
Table 81. Middle East & Africa IBS-C Drug Sales by Distribution Channel (2023-2028) & (K Units)
Table 82. IBS-C Drug Raw Material
Table 83. Key Manufacturers of IBS-C Drug Raw Materials
Table 84. Direct Channel Pros & Cons
Table 85. Indirect Channel Pros & Cons
Table 86. IBS-C Drug Typical Distributors
Table 87. IBS-C Drug Typical Customers
LIST OF FIGURES
Figure 1. IBS-C Drug Picture
Figure 2. Global IBS-C Drug Revenue Market Share by Type in 2021
Figure 3. Amitiza
Figure 4. Lactulose
Figure 5. Milk of Magnesia
Figure 6. LINZESS (Linaclotide)
Figure 7. Others
Figure 8. Global IBS-C Drug Revenue Market Share by Distribution Channel in 2021
Figure 9. Hospital Pharmacies
Figure 10. Retail Pharmacies
Figure 11. Online Pharmacies
Figure 12. Global IBS-C Drug Revenue, (USD Million) & (K Units): 2017 & 2021 & 2028
Figure 13. Global IBS-C Drug Revenue and Forecast (2017-2028) & (USD Million)
Figure 14. Global IBS-C Drug Sales (2017-2028) & (K Units)
Figure 15. Global IBS-C Drug Price (2017-2028) & (USD/Unit)
Figure 16. Global IBS-C Drug Production Capacity (2017-2028) & (K Units)
Figure 17. Global IBS-C Drug Production Capacity by Geographic Region: 2022 VS 2028
Figure 18. IBS-C Drug Market Drivers
Figure 19. IBS-C Drug Market Restraints
Figure 20. IBS-C Drug Market Trends
Figure 21. Global IBS-C Drug Sales Market Share by Manufacturer in 2021
Figure 22. Global IBS-C Drug Revenue Market Share by Manufacturer in 2021
Figure 23. IBS-C Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3) in 2021
Figure 24. Top 3 IBS-C Drug Manufacturer (Revenue) Market Share in 2021
Figure 25. Top 6 IBS-C Drug Manufacturer (Revenue) Market Share in 2021
Figure 26. Global IBS-C Drug Sales Market Share by Region (2017-2028)
Figure 27. Global IBS-C Drug Revenue Market Share by Region (2017-2028)
Figure 28. North America IBS-C Drug Revenue (2017-2028) & (USD Million)
Figure 29. Europe IBS-C Drug Revenue (2017-2028) & (USD Million)
Figure 30. Asia-Pacific IBS-C Drug Revenue (2017-2028) & (USD Million)
Figure 31. South America IBS-C Drug Revenue (2017-2028) & (USD Million)
Figure 32. Middle East & Africa IBS-C Drug Revenue (2017-2028) & (USD Million)
Figure 33. Global IBS-C Drug Sales Market Share by Type (2017-2028)
Figure 34. Global IBS-C Drug Revenue Market Share by Type (2017-2028)
Figure 35. Global IBS-C Drug Price by Type (2017-2028) & (USD/Unit)
Figure 36. Global IBS-C Drug Sales Market Share by Distribution Channel (2017-2028)
Figure 37. Global IBS-C Drug Revenue Market Share by Distribution Channel (2017-2028)
Figure 38. Global IBS-C Drug Price by Distribution Channel (2017-2028) & (USD/Unit)
Figure 39. North America IBS-C Drug Sales Market Share by Type (2017-2028)
Figure 40. North America IBS-C Drug Sales Market Share by Distribution Channel (2017-2028)
Figure 41. North America IBS-C Drug Sales Market Share by Country (2017-2028)
Figure 42. North America IBS-C Drug Revenue Market Share by Country (2017-2028)
Figure 43. United States IBS-C Drug Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 44. Canada IBS-C Drug Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 45. Mexico IBS-C Drug Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 46. Europe IBS-C Drug Sales Market Share by Type (2017-2028)
Figure 47. Europe IBS-C Drug Sales Market Share by Distribution Channel (2017-2028)
Figure 48. Europe IBS-C Drug Sales Market Share by Country (2017-2028)
Figure 49. Europe IBS-C Drug Revenue Market Share by Country (2017-2028)
Figure 50. Germany IBS-C Drug Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 51. France IBS-C Drug Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 52. United Kingdom IBS-C Drug Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 53. Russia IBS-C Drug Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 54. Italy IBS-C Drug Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 55. Asia-Pacific IBS-C Drug Sales Market Share by Region (2017-2028)
Figure 56. Asia-Pacific IBS-C Drug Sales Market Share by Distribution Channel (2017-2028)
Figure 57. Asia-Pacific IBS-C Drug Sales Market Share by Region (2017-2028)
Figure 58. Asia-Pacific IBS-C Drug Revenue Market Share by Region (2017-2028)
Figure 59. China IBS-C Drug Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 60. Japan IBS-C Drug Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 61. Korea IBS-C Drug Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 62. India IBS-C Drug Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 63. Southeast Asia IBS-C Drug Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 64. Australia IBS-C Drug Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 65. South America IBS-C Drug Sales Market Share by Type (2017-2028)
Figure 66. South America IBS-C Drug Sales Market Share by Distribution Channel (2017-2028)
Figure 67. South America IBS-C Drug Sales Market Share by Country (2017-2028)
Figure 68. South America IBS-C Drug Revenue Market Share by Country (2017-2028)
Figure 69. Brazil IBS-C Drug Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 70. Argentina IBS-C Drug Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 71. Middle East & Africa IBS-C Drug Sales Market Share by Type (2017-2028)
Figure 72. Middle East & Africa IBS-C Drug Sales Market Share by Distribution Channel (2017-2028)
Figure 73. Middle East & Africa IBS-C Drug Sales Market Share by Region (2017-2028)
Figure 74. Middle East & Africa IBS-C Drug Revenue Market Share by Region (2017-2028)
Figure 75. Turkey IBS-C Drug Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 76. Egypt IBS-C Drug Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 77. Saudi Arabia IBS-C Drug Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 78. South Africa IBS-C Drug Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 79. Manufacturing Cost Structure Analysis of IBS-C Drug in 2021
Figure 80. Manufacturing Process Analysis of IBS-C Drug
Figure 81. IBS-C Drug Industrial Chain
Figure 82. Sales Channel: Direct Channel vs Indirect Channel
Figure 83. Methodology
Figure 84. Research Process and Data Source
Figure 1. IBS-C Drug Picture
Figure 2. Global IBS-C Drug Revenue Market Share by Type in 2021
Figure 3. Amitiza
Figure 4. Lactulose
Figure 5. Milk of Magnesia
Figure 6. LINZESS (Linaclotide)
Figure 7. Others
Figure 8. Global IBS-C Drug Revenue Market Share by Distribution Channel in 2021
Figure 9. Hospital Pharmacies
Figure 10. Retail Pharmacies
Figure 11. Online Pharmacies
Figure 12. Global IBS-C Drug Revenue, (USD Million) & (K Units): 2017 & 2021 & 2028
Figure 13. Global IBS-C Drug Revenue and Forecast (2017-2028) & (USD Million)
Figure 14. Global IBS-C Drug Sales (2017-2028) & (K Units)
Figure 15. Global IBS-C Drug Price (2017-2028) & (USD/Unit)
Figure 16. Global IBS-C Drug Production Capacity (2017-2028) & (K Units)
Figure 17. Global IBS-C Drug Production Capacity by Geographic Region: 2022 VS 2028
Figure 18. IBS-C Drug Market Drivers
Figure 19. IBS-C Drug Market Restraints
Figure 20. IBS-C Drug Market Trends
Figure 21. Global IBS-C Drug Sales Market Share by Manufacturer in 2021
Figure 22. Global IBS-C Drug Revenue Market Share by Manufacturer in 2021
Figure 23. IBS-C Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3) in 2021
Figure 24. Top 3 IBS-C Drug Manufacturer (Revenue) Market Share in 2021
Figure 25. Top 6 IBS-C Drug Manufacturer (Revenue) Market Share in 2021
Figure 26. Global IBS-C Drug Sales Market Share by Region (2017-2028)
Figure 27. Global IBS-C Drug Revenue Market Share by Region (2017-2028)
Figure 28. North America IBS-C Drug Revenue (2017-2028) & (USD Million)
Figure 29. Europe IBS-C Drug Revenue (2017-2028) & (USD Million)
Figure 30. Asia-Pacific IBS-C Drug Revenue (2017-2028) & (USD Million)
Figure 31. South America IBS-C Drug Revenue (2017-2028) & (USD Million)
Figure 32. Middle East & Africa IBS-C Drug Revenue (2017-2028) & (USD Million)
Figure 33. Global IBS-C Drug Sales Market Share by Type (2017-2028)
Figure 34. Global IBS-C Drug Revenue Market Share by Type (2017-2028)
Figure 35. Global IBS-C Drug Price by Type (2017-2028) & (USD/Unit)
Figure 36. Global IBS-C Drug Sales Market Share by Distribution Channel (2017-2028)
Figure 37. Global IBS-C Drug Revenue Market Share by Distribution Channel (2017-2028)
Figure 38. Global IBS-C Drug Price by Distribution Channel (2017-2028) & (USD/Unit)
Figure 39. North America IBS-C Drug Sales Market Share by Type (2017-2028)
Figure 40. North America IBS-C Drug Sales Market Share by Distribution Channel (2017-2028)
Figure 41. North America IBS-C Drug Sales Market Share by Country (2017-2028)
Figure 42. North America IBS-C Drug Revenue Market Share by Country (2017-2028)
Figure 43. United States IBS-C Drug Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 44. Canada IBS-C Drug Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 45. Mexico IBS-C Drug Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 46. Europe IBS-C Drug Sales Market Share by Type (2017-2028)
Figure 47. Europe IBS-C Drug Sales Market Share by Distribution Channel (2017-2028)
Figure 48. Europe IBS-C Drug Sales Market Share by Country (2017-2028)
Figure 49. Europe IBS-C Drug Revenue Market Share by Country (2017-2028)
Figure 50. Germany IBS-C Drug Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 51. France IBS-C Drug Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 52. United Kingdom IBS-C Drug Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 53. Russia IBS-C Drug Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 54. Italy IBS-C Drug Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 55. Asia-Pacific IBS-C Drug Sales Market Share by Region (2017-2028)
Figure 56. Asia-Pacific IBS-C Drug Sales Market Share by Distribution Channel (2017-2028)
Figure 57. Asia-Pacific IBS-C Drug Sales Market Share by Region (2017-2028)
Figure 58. Asia-Pacific IBS-C Drug Revenue Market Share by Region (2017-2028)
Figure 59. China IBS-C Drug Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 60. Japan IBS-C Drug Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 61. Korea IBS-C Drug Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 62. India IBS-C Drug Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 63. Southeast Asia IBS-C Drug Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 64. Australia IBS-C Drug Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 65. South America IBS-C Drug Sales Market Share by Type (2017-2028)
Figure 66. South America IBS-C Drug Sales Market Share by Distribution Channel (2017-2028)
Figure 67. South America IBS-C Drug Sales Market Share by Country (2017-2028)
Figure 68. South America IBS-C Drug Revenue Market Share by Country (2017-2028)
Figure 69. Brazil IBS-C Drug Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 70. Argentina IBS-C Drug Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 71. Middle East & Africa IBS-C Drug Sales Market Share by Type (2017-2028)
Figure 72. Middle East & Africa IBS-C Drug Sales Market Share by Distribution Channel (2017-2028)
Figure 73. Middle East & Africa IBS-C Drug Sales Market Share by Region (2017-2028)
Figure 74. Middle East & Africa IBS-C Drug Revenue Market Share by Region (2017-2028)
Figure 75. Turkey IBS-C Drug Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 76. Egypt IBS-C Drug Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 77. Saudi Arabia IBS-C Drug Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 78. South Africa IBS-C Drug Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 79. Manufacturing Cost Structure Analysis of IBS-C Drug in 2021
Figure 80. Manufacturing Process Analysis of IBS-C Drug
Figure 81. IBS-C Drug Industrial Chain
Figure 82. Sales Channel: Direct Channel vs Indirect Channel
Figure 83. Methodology
Figure 84. Research Process and Data Source
